Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | adenosine A1 receptor | Starlite/ChEMBL | References |
Homo sapiens | adenosine A3 receptor | Starlite/ChEMBL | References |
Homo sapiens | adenosine A2a receptor | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Brugia malayi | hypothetical protein | adenosine A1 receptor | 326 aa | 305 aa | 21.0 % |
Brugia malayi | follicle stimulating hormone receptor | adenosine A2a receptor | 412 aa | 336 aa | 22.3 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Brugia malayi | Latrophilin receptor protein 2 | 0.0032 | 0.1008 | 0.1479 |
Schistosoma mansoni | hypothetical protein | 0.0171 | 1 | 1 |
Schistosoma mansoni | tar DNA-binding protein | 0.0063 | 0.2985 | 0.2198 |
Loa Loa (eye worm) | latrophilin receptor protein 2 | 0.0032 | 0.1008 | 0.0682 |
Schistosoma mansoni | hypothetical protein | 0.0171 | 1 | 1 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.0101 | 0.5482 | 0.8042 |
Trypanosoma brucei | PAB1-binding protein , putative | 0.0025 | 0.0583 | 0.5 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.0025 | 0.0583 | 0.5 |
Brugia malayi | RNA recognition motif domain containing protein | 0.0063 | 0.2985 | 0.4379 |
Leishmania major | hypothetical protein, conserved | 0.0025 | 0.0583 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0069 | 0.3412 | 0.2673 |
Brugia malayi | hypothetical protein | 0.0037 | 0.1312 | 0.1925 |
Schistosoma mansoni | tar DNA-binding protein | 0.0063 | 0.2985 | 0.2198 |
Entamoeba histolytica | hypothetical protein | 0.0037 | 0.1312 | 0.5 |
Plasmodium vivax | ataxin-2 like protein, putative | 0.0025 | 0.0583 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0032 | 0.1008 | 0.0682 |
Echinococcus granulosus | tar DNA binding protein | 0.0063 | 0.2985 | 0.2198 |
Brugia malayi | MH2 domain containing protein | 0.0122 | 0.6817 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0037 | 0.1312 | 0.0338 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.0025 | 0.0583 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0069 | 0.3412 | 0.4537 |
Entamoeba histolytica | hypothetical protein | 0.0037 | 0.1312 | 0.5 |
Brugia malayi | calcium-independent alpha-latrotoxin receptor 2, putative | 0.0032 | 0.1008 | 0.1479 |
Loa Loa (eye worm) | RNA binding protein | 0.0063 | 0.2985 | 0.3853 |
Echinococcus multilocularis | tar DNA binding protein | 0.0063 | 0.2985 | 0.2198 |
Brugia malayi | TAR-binding protein | 0.0063 | 0.2985 | 0.4379 |
Schistosoma mansoni | tar DNA-binding protein | 0.0063 | 0.2985 | 0.2198 |
Echinococcus granulosus | Basic leucine zipper bZIP transcription | 0.0037 | 0.1312 | 0.0338 |
Toxoplasma gondii | LsmAD domain-containing protein | 0.0025 | 0.0583 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0101 | 0.5482 | 0.7859 |
Echinococcus multilocularis | Basic leucine zipper (bZIP) transcription | 0.0037 | 0.1312 | 0.0338 |
Schistosoma mansoni | tar DNA-binding protein | 0.0063 | 0.2985 | 0.2198 |
Schistosoma mansoni | tar DNA-binding protein | 0.0063 | 0.2985 | 0.2198 |
Echinococcus multilocularis | geminin | 0.0171 | 1 | 1 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.0122 | 0.6817 | 1 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.0101 | 0.5482 | 0.8042 |
Brugia malayi | hypothetical protein | 0.0025 | 0.0583 | 0.0856 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0122 | 0.6817 | 1 |
Schistosoma mansoni | transcription factor LCR-F1 | 0.0037 | 0.1312 | 0.0338 |
Loa Loa (eye worm) | RNA recognition domain-containing protein domain-containing protein | 0.0063 | 0.2985 | 0.3853 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.0025 | 0.0583 | 0.5 |
Brugia malayi | RNA binding protein | 0.0063 | 0.2985 | 0.4379 |
Loa Loa (eye worm) | TAR-binding protein | 0.0063 | 0.2985 | 0.3853 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.0101 | 0.5482 | 0.7859 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.0025 | 0.0583 | 0.5 |
Entamoeba histolytica | hypothetical protein | 0.0037 | 0.1312 | 0.5 |
Entamoeba histolytica | hypothetical protein | 0.0037 | 0.1312 | 0.5 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0069 | 0.3412 | 0.5004 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Inhibition (binding) | = 2 % | Displacement of [3H]DPCPX from human adenosine A2B receptor expressed in HEK293 cells at 0.1 uM by liquid scintillation counting | ChEMBL. | 21186795 |
Inhibition (binding) | = 6 % | Displacement of [3H]DPCPX from human adenosine A2B receptor expressed in HEK-293 cells at 1 uM | ChEMBL. | 23231967 |
Ki (binding) | = 8.48 | Displacement of [3H]NECA from human adenosine A3 receptor expressed in human HeLa cells | ChEMBL. | 23231967 |
Ki (binding) | = 3.3 nM | Displacement of [3H]NECA from human adenosine A3 receptor expressed in human HeLa cells by liquid scintillation counting | ChEMBL. | 21186795 |
Ki (binding) | = 3.3 nM | Displacement of [3H]NECA from human adenosine A3 receptor expressed in human HeLa cells | ChEMBL. | 23231967 |
Ki (binding) | = 17 nM | Displacement of [3H]DPCPX from human adenosine A1 receptor expressed in CHO cells | ChEMBL. | 23231967 |
Ki (binding) | = 17.7 nM | Displacement of [3H]DPCPX from human adenosine A1 receptor expressed in CHO cells by liquid scintillation counting | ChEMBL. | 21186795 |
Ki (binding) | = 3345 nM | Displacement of [3H]ZM2413853 from human adenosine A2A receptor expressed in human HeLa cells by liquid scintillation counting | ChEMBL. | 21186795 |
Ki (binding) | = 3345 nM | Displacement of [3H]4-(2-[7-Amino-2-(2-furyl) [1,2,4]triazolo[2,3-alpha] [1,3,5]triazin-5-ylamino]ethyl)phenol from human adenosine A2A receptor expressed in human HeLa cells | ChEMBL. | 23231967 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
2 literature references were collected for this gene.